This proposed project aims to validate and refine a novel MRI technique that uses targeting MR contrast probes to detect altered endogenous gene expression resulting from amphetamine exposure in living animals. We will use an animal model of addiction in C57Black6 mice. The targets to be investigated in this project are mRNA of a transcription factor fosB and the activator protein 1 (AP-1) whose altered expression is strongly implicated in drug addiction. ? ? Most current molecular imaging methods detect cell surface proteins as markers of gene expression. Our proposed technique detects intracellular products of gene expression, such as mRNA and its products that may have DNA binding ability in the brains of living mice. This method uses DNA with antisense sequence to the target mRNA or DNA with consensus sequence for AP-1 binding. In preliminary studies, we labeled these DNA with MR contrast agent and showed in a proof-of-concept study that the probe is capable of reporting elevation of c-fos mRNA live animals using MRI after acute amphetamine injection. ? ? Our goals are to extend and improve the sensitivity of this technique and establish the correlate between MR signal and histological assessment of intracellular targets. By achieving these goals, we will be able to apply this novel MR technique as a quantitative tool for the detection of endogenous gene expression of other genes such as cyclic AMP responsive elements (CREB) and a host of other products of gene expression that are implicated in drug addiction.Project Narrative: ? ? In this project, we will extend and refine a novel Magnetic Resonance Imaging (MRI) technique that we have developed to detect altered gene expression in the brains of live animal affected by addictive drugs. The goal of this project is to make this technique a quantitative tool to measure endogenous gene expression in the brains. Such enhancement will bring a step closer to real-time analysis of neurophysiologic events that occur in patients with substance abuse and addiction. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21DA024235-02
Application #
7503404
Study Section
Neural Basis of Psychopathology, Addictions and Sleep Disorders Study Section (NPAS)
Program Officer
Wu, Da-Yu
Project Start
2007-09-30
Project End
2010-08-31
Budget Start
2008-09-01
Budget End
2010-08-31
Support Year
2
Fiscal Year
2008
Total Cost
$213,868
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Eikermann-Haerter, Katharina; Lee, Jeong Hyun; Yuzawa, Izumi et al. (2012) Migraine mutations increase stroke vulnerability by facilitating ischemic depolarizations. Circulation 125:335-45
Liu, Philip K; Liu, Christina H (2011) Gene targeting MRI: nucleic acid-based imaging and applications. Methods Mol Biol 711:363-77
Liu, Christina H; Ren, Jia Q; Yang, Jinsheng et al. (2009) DNA-based MRI probes for specific detection of chronic exposure to amphetamine in living brains. J Neurosci 29:10663-70
Liu, Christina H; You, Zerong; Liu, Charng-Ming et al. (2009) Diffusion-weighted magnetic resonance imaging reversal by gene knockdown of matrix metalloproteinase-9 activities in live animal brains. J Neurosci 29:3508-17
Liu, Christina H; You, Zerong; Ren, JiaQian et al. (2008) Noninvasive delivery of gene targeting probes to live brains for transcription MRI. FASEB J 22:1193-203